Q2 2026 Holdings
Filed 2026-08-14 | 39 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $237.1M | 4,311,092 | 15.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $234.9M | 632,005 | 15.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $129.1M | 3,945,920 | 8.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $104.1M | 4,911,590 | 7.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $98.8M | 4,073,787 | 6.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $78.1M | 6,739,675 | 5.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $67.8M | 11,869,877 | 4.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $52.3M | 4,368,804 | 3.5% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $47.8M | 6,892,033 | 3.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $44.4M | 1,412,199 | 3.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $40.0M | 1,164,259 | 2.7% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $35.5M | 2,733,926 | 2.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $34.8M | 12,872,946 | 2.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $23.9M | 640,202 | 1.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $23.8M | 2,164,777 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.5M | 503,321 | 1.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $19.5M | 1,948,695 | 1.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $17.2M | 3,031,009 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $16.1M | 433,921 | 1.1% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $16.0M | 1,226,330 | 1.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $15.3M | 7,392,504 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $15.2M | 265,169 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.8M | 229,374 | 0.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $12.9M | 491,654 | 0.9% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $12.3M | 11,526,710 | 0.8% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $11.8M | 1,666,667 | 0.8% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $8.0M | 425,000 | 0.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $7.7M | 93,154 | 0.5% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $7.6M | 88,964 | 0.5% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $7.5M | 386,786 | 0.5% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $6.7M | 410,440 | 0.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.5M | 51,234 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $5.1M | 1,389,632 | 0.3% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $5.1M | 441,701 | 0.3% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $4.0M | 611,400 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.9M | 362,010 | 0.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.3M | 641,750 | 0.2% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.3M | 2,597,759 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $880.2K | 772,126 | 0.1% |